Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 1
2005 7
2006 11
2007 2
2008 8
2009 10
2010 6
2011 9
2012 4
2013 8
2014 10
2015 10
2016 15
2017 4
2018 2
2019 7
2020 7
2021 16
2022 14
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic Challenges in Inflammatory Choroidal Neovascularization.
Karska-Basta I, Pociej-Marciak W, Żuber-Łaskawiec K, Markiewicz A, Chrząszcz M, Romanowska-Dixon B, Kubicka-Trząska A. Karska-Basta I, et al. Among authors: romanowska dixon b. Medicina (Kaunas). 2024 Mar 12;60(3):465. doi: 10.3390/medicina60030465. Medicina (Kaunas). 2024. PMID: 38541191 Free PMC article. Review.
Use of Optical Coherence Tomography and Optical Coherence Tomography Angiography in the Diagnosis and Follow-Up of Endogenous Candida Endophthalmitis: A Case Report.
Kubicka-Trząska A, Bugara D, Żuber-Łaskawiec K, Pociej-Marciak W, Markiewicz A, Romanowska-Dixon B, Karska-Basta I. Kubicka-Trząska A, et al. Among authors: romanowska dixon b. Medicina (Kaunas). 2024 Jan 25;60(2):207. doi: 10.3390/medicina60020207. Medicina (Kaunas). 2024. PMID: 38399495 Free PMC article.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Ophthalmic applicator displacement as a method of treating large diffuse uveal melanomas.
Markiewicz A, Skórkiewicz K, Bogdał A, Medoń D, Świder M, Korab-Chrzanowska EB, Kowal J, Dębicka-Kumela M, Romanowska-Dixon B. Markiewicz A, et al. Among authors: romanowska dixon b. J Contemp Brachytherapy. 2023 Jun;15(3):184-190. doi: 10.5114/jcb.2023.128920. Epub 2023 Jun 26. J Contemp Brachytherapy. 2023. PMID: 37425204 Free PMC article.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
165 results